Novo Nordisk A/S has announced trading activities involving its shares by board members, executives, and associated persons. Martin Holst Lange, an Executive Vice President, sold 13,950 shares of Novo Nordisk B, identification code DK0062498333, on August 7, 2025. The transactions were conducted outside a trading venue and at Citigroup Global Markets Europe AG - EMEA Trading. The company disclosed this information in compliance with market abuse regulations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.